Primary prevention of cardiovascular disease in diabetes mellitus

JD Newman, AZ Schwartzbard, HS Weintraub… - Journal of the American …, 2017 - jacc.org
Type 2 diabetes mellitus (T2D) is a major risk factor for cardiovascular disease (CVD), the
most common cause of death in T2D. Yet,< 50% of US adults with T2D meet recommended …

[HTML][HTML] Cardiovascular protection in the treatment of type 2 diabetes: a review of clinical trial results across drug classes

F Paneni, TF Lüscher - The American journal of cardiology, 2017 - Elsevier
Patients with type 2 diabetes (T2DM) have a significantly higher risk of developing
cardiovascular disease (CVD)—namely myocardial infarction, heart failure, and stroke …

[HTML][HTML] What people with Down Syndrome can teach us about cardiopulmonary disease

KL Colvin, ME Yeager - European Respiratory Review, 2017 - Eur Respiratory Soc
Down syndrome is the most common chromosomal abnormality among live-born infants.
Through full or partial trisomy of chromosome 21, Down syndrome is associated with …

[HTML][HTML] Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes

K Mohammedi, M Woodward, M Marre… - Cardiovascular …, 2017 - Springer
Background Microvascular disease is associated with a high risk of macrovascular events in
patients with type 2 diabetes, but the impact of macrovascular disease on the risk of …

[HTML][HTML] Extracellular vesicles as protagonists of diabetic cardiovascular pathology

D Gustafson, S Veitch, JE Fish - Frontiers in cardiovascular medicine, 2017 - frontiersin.org
Extracellular vesicles (EVs) represent an emerging mechanism of cell–cell communication
in the cardiovascular system. Recent data suggest that EVs are produced and taken up by …

[HTML][HTML] Heat shock proteins in vascular diabetic complications: review and future perspective

S Bellini, F Barutta, R Mastrocola, L Imperatore… - International journal of …, 2017 - mdpi.com
Heat shock proteins (HSPs) are a large family of proteins highly conserved throughout
evolution because of their unique cytoprotective properties. Besides assisting protein …

An evidence-based medicine approach to antihyperglycemic therapy in diabetes mellitus to overcome overtreatment

AN Makam, OK Nguyen - Circulation, 2017 - Am Heart Assoc
Overtreatment is pervasive in medicine and leads to potential patient harms and excessive
costs in health care. Although evidence-based medicine is often derided as practice by rote …

Treatment of dyslipidemias to prevent cardiovascular disease in patients with type 2 diabetes

M Khavandi, F Duarte, HN Ginsberg… - Current cardiology …, 2017 - Springer
Abstract Purpose of Review Current preventive and treatment guidelines for type 2 diabetes
have failed to decrease the incidence of comorbidities, such as dyslipidemia and ultimately …

Efficacy and safety of Gegen Qinlian decoction for normalizing hyperglycemia in diabetic patients: a systematic review and meta-analysis of randomized clinical trials

JA Ryuk, M Lixia, S Cao, BS Ko, S Park - Complementary Therapies in …, 2017 - Elsevier
Objectives A systematic review and meta-analysis was conducted to evaluate the efficacy
and safety of Gegen Qinlian decoction (GQD) for normalizing hyperglycemia in T2DM …

Relationship between diabetes and ischaemic injury among patients with revascularized ST‐elevation myocardial infarction

SJ Reinstadler, T Stiermaier, C Eitel… - Diabetes, Obesity …, 2017 - Wiley Online Library
Aims Studies comparing reperfusion efficacy and myocardial damage between diabetic and
non‐diabetic patients with ST‐elevation myocardial infarction (STEMI) are scarce and have …